Kerper, LE|Goodman, JE|Petito Boyce, C|Prueitt, RL|Rhomberg, LR 2010
Weight-of-Evidence Analysis of Exposures to Dioxins and Dioxin-like Compounds and Associations with Thyroid Hormone Levels During Early Development.
Presented at the Society of Toxicology (SOT) 49th Annual Meeting, Salt Lake City, UT
Wait, AD|Reid, KR|Occhialini, J|Todaro, J 2010
Time travel, fabrication, manipulation, and spoliation: Threats to data quality.
Environ. Claims J.
Rhomberg, LR|Goodman, JE|Lewandowski, TA 2010
Chapter 1.20: Risk assessment.
Comprehensive Toxicology (Second Edition). Volume 1: General Principles. (Ed.: Bond, J), Elsevier Ltd., United Kingdom
Lewis, AS|Beck, BD 2010
Nonlinear low-dose extrapolations.
In Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification. (Eds.: Hsu, CH; Stedeford, T), John Wiley & Sons, Inc., Hoboken, NJ
Goodman, JE|Kerper, LE|Petito Boyce, C|Prueitt, RL|Rhomberg, LR 2010
Weight-of-evidence analysis of human exposures to dioxins and dioxin-like compounds and associations with thyroid hormone levels during early development.
Regul. Toxicol. Pharmacol.
Rhomberg, LR 2010
Toxicity testing in the 21st century: How will it affect risk assessment?
J. Toxicol. Environ. Health B
Goodman, JE|Dodge, DG|Bailey, LA 2010
A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide.
Regul. Toxicol. Pharmacol.
Wait, AD 2010
Data quality and transparency in the dietary supplement industry.
Food Drug Law J.
Rhomberg, LR|Bailey, LA|Goodman, JE 2010
Hypothesis-based weight of evidence: A tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action – Naphthalene as an example.
Crit. Rev. Toxicol.
Herman, KD|Bittner, A 2010
How Much Tar is in the Mud? Reducing Uncertainty in Characterizing the Distribution and Mass of DNAPL in Sediments.
EPRI MGP Symposium, San Antonio, Texas
Glynn, SA|Prueitt, RL|Ridnour, LA|Boersma, BJ|Dorsey, TM|Wink, DA|Goodman, JE|Yfantis, HG|Lee, DH|Ambs, S 2010
COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer.
BMC Cancer
Sharma, M 2009 (Winter)
Regulatory framework for PIE [pharmaceuticals in the environment].
Gradient Trends - Risk Science & Application
Verslycke, T 2009 (Winter)
Are pharmaceuticals posing a risk to the environment?
Gradient Trends - Risk Science & Application
Bittner, AB 2009 (Spring)
Is your NAPL mobile?
Gradient Trends - Risk Science & Application
Herman, KD 2009 (Spring)
Sediment DNAPL challenges.
Gradient Trends - Risk Science & Application
